Characteristics of Living Systematic Review for COVID-19

References

• CNN health. Tracking Covid-19ʹs global spread; 2022. Available from: https://edition.cnn.com/interactive/2020/health/coronavirus-maps-and-cases/. Accessed May 16, 2022.
   Google Scholar
• World Health Organization. WHO coronavirus disease (COVID-19) dashboard; 2022. Available from: https://covid19.who.int/. Accessed August 1, 2022.
   Google Scholar
• Cai X, Fry CV, Wagner CS. International collaboration during the COVID-19 crisis: autumn 2020 developments. Scientometrics. 2021;126(4):3683–3692. doi:10.1007/s11192-021-03873-7
   PubMed Web of Science ®Google Scholar
• Else H. How a torrent of COVID science changed research publishing — in seven charts. Nature. 2020;588(7839):553. doi:10.1038/d41586-020-03564-y
   PubMed Web of Science ®Google Scholar
• Ramanan M, Stolz A, Rooplalsingh R, et al. An evaluation of the quality and impact of the global research response to the COVID-19 pandemic. Med J Aust. 2020;213(8):380–80.e1. doi:10.5694/mja2.50790
   Web of Science ®Google Scholar
• Casigliani V, De Nard F, De Vita E, et al. Too much information, too little evidence: is waste in research fuelling the covid-19 infodemic? BMJ. 2020;370:m2672. doi:10.1136/bmj.m2672
   Web of Science ®Google Scholar
• Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med. 2014;11(2):e1001603. doi:10.1371/journal.pmed.1001603
   PubMed Web of Science ®Google Scholar
• Millard T, Synnot A, Elliott J, et al. Feasibility and acceptability of living systematic reviews: results from a mixed-methods evaluation. Syst Rev. 2019;8(1):325–425. doi:10.1186/s13643-019-1248-5
   Web of Science ®Google Scholar
• Iannizzi C, Akl EA, Kahale LA, et al. Methods and guidance on conducting, reporting, publishing and appraising living systematic reviews: a scoping review protocol. F1000Res. 2021;10:802–902. doi:10.12688/f1000research.55108.1
   Google Scholar
• Ji DH XU. A brief introduction of living systematic review. Chin J Evid Based Med. 2020;20(2):244–248.
   Google Scholar
• Jadad AR, Cook DJ, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA. 1998;280(3):278–280. doi:10.1001/jama.280.3.278
   PubMed Web of Science ®Google Scholar
• Brooker J, Synnot A, McDonald S,et al. Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode; 2019. Available from: https://community.cochrane.org/sites/default/files/uploads/inline-files/Transform/201912_LSR_Revised_Guidance.pdf. Accessed March 9, 2022.
   Google Scholar
• Negrini S, Ceravolo MG, Côté P, et al. A systematic review that is ``rapid’’ and ``living’’: a specific answer to the COVID-19 pandemic. J Clin Epidemiol. 2021;138:194–198. doi:10.1016/j.jclinepi.2021.05.025
   Web of Science ®Google Scholar
• Iannizzi C, Dorando E, Burns J, et al. Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper. J Clin Epidemiol. 2022;141:82–89. doi:10.1016/j.jclinepi.2021.09.013
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535. doi:10.1136/bmj.b2535
   PubMed Web of Science ®Google Scholar
• Allotey J, Chatterjee S, Kew T, et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ. 2022;376:e067696. doi:10.1136/bmj-2021-067696
   Web of Science ®Google Scholar
• Allotey J, Fernandez S, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi:10.1136/bmj.m3320
   PubMed Web of Science ®Google Scholar
• Amer YS, Titi MA, Godah MW, et al. International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review. J Clin Epidemiol. 2022;142:333–370. doi:10.1016/j.jclinepi.2021.11.010
   Web of Science ®Google Scholar
• Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral manifestations in patients with COVID-19: a 6-month update. J Dent Res. 2021;100(12):1321–1329. doi:10.1177/00220345211029637
   PubMed Web of Science ®Google Scholar
• Ansems K, Grundeis F, Dahms K, et al. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021;8(8):Cd014962. doi:10.1002/14651858.Cd014962
   PubMed Web of Science ®Google Scholar
• Asiimwe IG, Pushpakom S, Turner RM, et al. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(12):4534–4545. doi:10.1111/bcp.14927
   Web of Science ®Google Scholar
• Baladia E, Pizarro AB, Ortiz-Muñoz L, et al. Vitamin C for COVID-19: a living systematic review. Medwave. 2020;20(6):e7978. doi:10.5867/medwave.2020.06.7978
   PubMed Web of Science ®Google Scholar
• Bartoszko JJ, Siemieniuk RAC, Kum E, et al. Prophylaxis against covid-19: living systematic review and network meta-analysis. BMJ. 2021;373(949). doi:10.1136/bmj.n949
   Web of Science ®Google Scholar
• Bell V, Wade D. Mental health of clinical staff working in high-risk epidemic and pandemic health emergencies a rapid review of the evidence and living meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2021;56(1):1–11. doi:10.1007/s00127-020-01990-x
   PubMed Web of Science ®Google Scholar
• Bonardi O, Wang Y, Li K, et al. Effects of COVID-19 mental health interventions among children, adolescents, and adults not quarantined or undergoing treatment due to COVID-19 infection: a systematic review of randomised controlled trials. The Canadian Journal of Psychiatry. 2022;67(5):336–350. doi:10.1177/07067437211070648
   PubMed Web of Science ®Google Scholar
• Brümmer LE, Katzenschlager S, Gaeddert M, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLoS Med. 2021;18(8):e1003735. doi:10.1371/journal.pmed.1003735
   PubMed Web of Science ®Google Scholar
• Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003346. doi:10.1371/journal.pmed.1003346
   PubMed Web of Science ®Google Scholar
• Bwire GM, Njiro BJ, Mwakawanga DL, et al. Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: a living systematic review. J Med Virol. 2021;93(3):1361–1369. doi:10.1002/jmv.26622
   PubMed Web of Science ®Google Scholar
• Cares-Marambio K, Montenegro-Jiménez Y, Torres-Castro R, et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis. 2021;18:14799731211002240. doi:10.1177/14799731211002240
   Web of Science ®Google Scholar
• Centeno‐Tablante E, Medina‐Rivera M, Finkelstein JL, et al. Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review. Ann N Y Acad Sci. 2021;1484(1):32–54. doi:10.1111/nyas.14477
   PubMed Web of Science ®Google Scholar
• Ceravolo MG, Andrenelli E, Arienti C, et al. Rehabilitation and COVID-19: rapid living systematic review by cochrane rehabilitation field - third edition. Eur J Phys Rehabil Med. 2021;57(5):850–857. doi:10.23736/s1973-9087.21.07301-9
   Web of Science ®Google Scholar
• Davidson M, Menon S, Chaimani A, et al. Interleukin-1 blocking agents for treating COVID-19. Cochrane Database Syst Rev. 2022;1(1):Cd015308. doi:10.1002/14651858.Cd015308
   Web of Science ®Google Scholar
• Deeks JJ, Dinnes J, Takwoingi Y, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020;6(6):Cd013652. doi:10.1002/14651858.Cd013652
   PubMed Web of Science ®Google Scholar
• Dong F, Liu H-L, Dai N, et al. A living systematic review of the psychological problems in people suffering from COVID-19. J Affect Disord. 2021;292:172–188. doi:10.1016/j.jad.2021.05.060
   PubMed Web of Science ®Google Scholar
• Dzinamarira T, Nkambule SJ, Hlongwa M, et al. Risk factors for COVID-19 infection among healthcare workers. A first report from a living systematic review and meta-analysis. Saf Health Work. 2022. doi:10.1016/j.shaw.2022.04.001
   Web of Science ®Google Scholar
• Elvidge J, Summerfield A, Nicholls D, et al. Diagnostics and treatments of COVID-19: a living systematic review of economic evaluations. Value Health. 2022;25(5):773–784. doi:10.1016/j.jval.2022.01.001
   PubMed Web of Science ®Google Scholar
• Ghosn L, Chaimani A, Evrenoglou T, et al. Interleukin-6 blocking agents for treating COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021;3(3):Cd013881. doi:10.1002/14651858.Cd013881
   Web of Science ®Google Scholar
• Gómez-Ochoa SA, Franco OH, Rojas LZ, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190(1):161–175. doi:10.1093/aje/kwaa191
   PubMed Web of Science ®Google Scholar
• Griesel M, Wagner C, Mikolajewska A, et al. Inhaled corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2022;3(3):Cd015125. doi:10.1002/14651858.Cd015125
   Web of Science ®Google Scholar
• Harder T, Koch J, Vygen-Bonnet S, et al. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021. Euro Surv. 2021;26(28). doi:10.2807/1560-7917.Es.2021.26.28.2100563
   Google Scholar
• Harder T, Külper-Schiek W, Reda S, et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis. Euro Surv. 2021;26(41). doi:10.2807/1560-7917.Es.2021.26.41.2100920
   Google Scholar
• Helfand M, Fiordalisi C, Wiedrick J, et al. Risk for reinfection after SARS-CoV-2: a living, rapid review for American College of physicians practice points on the role of the antibody response in conferring immunity following SARS-CoV-2 infection. Ann Intern Med. 2022. doi:10.7326/m21-4245
   Web of Science ®Google Scholar
• Hernandez AV, Roman YM, Pasupuleti V, et al. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med. 2020;173(4):287–296. doi:10.7326/m20-2496
   PubMed Web of Science ®Google Scholar
• Hussain S, Riad A, Singh A, et al. Global prevalence of COVID-19-associated mucormycosis (CAM): living systematic review and meta-analysis. J Fungi. 2021;7(11). doi:10.3390/jof7110985
   Web of Science ®Google Scholar
• John A, Eyles E, Webb RT, et al. The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: update of living systematic review. F1000Res. 2020;9:1097. doi:10.12688/f1000research.25522.2
   PubMedGoogle Scholar
• Juul S, Nielsen EE, Feinberg J, et al. Interventions for treatment of COVID-19: a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS Med. 2020;17(9):e1003293. doi:10.1371/journal.pmed.1003293
   Web of Science ®Google Scholar
• Kirkham AM, Monaghan M, Bailey AJM, et al. Mesenchymal stem/stromal cell-based therapies for COVID-19: first iteration of a living systematic review and meta-analysis: mSCs and COVID-19. Cytotherapy. 2022. doi:10.1016/j.jcyt.2021.12.001
   Google Scholar
• Korang SK, von Rohden E, Veroniki AA, et al. Vaccines to prevent COVID-19: a living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials. PLoS One. 2022;17(1):e0260733. doi:10.1371/journal.pone.0260733
   PubMed Web of Science ®Google Scholar
• Kreuzberger N, Hirsch C, Chai KL, et al. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021;9(9):Cd013825. doi:10.1002/14651858.CD013825
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi:10.1016/j.cmi.2020.07.016
   PubMed Web of Science ®Google Scholar
• Mackey K, King VJ, Gurley S, et al. Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: a living systematic review. Ann Intern Med. 2020;173(3):195–203. doi:10.7326/m20-1515
   Web of Science ®Google Scholar
• Maguire BJ, McLean ARD, Rashan S, et al. Baseline results of a living systematic review for COVID-19 clinical trial registrations. Wellcome Open Res. 2020;5:116. doi:10.12688/wellcomeopenres.15933.1
   Google Scholar
• Melo AKG, Milby KM, Caparroz A, et al. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis. PLoS One. 2021;16(6):e0253894. doi:10.1371/journal.pone.0253894
   PubMed Web of Science ®Google Scholar
• Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Global Health. 2021;6(9). doi:10.1136/bmjgh-2021-005427
   Web of Science ®Google Scholar
• Mikolajewska A, Fischer AL, Piechotta V, et al. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021;10(10):Cd015045. doi:10.1002/14651858.Cd015045
   PubMed Web of Science ®Google Scholar
• O’Byrne L, Webster KE, MacKeith S, et al. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2021;7(7):Cd013876. doi:10.1002/14651858.CD013876
   Google Scholar
• Qiu X, Nergiz AI, Maraolo AE, et al. The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review. Clin Microbiol Infect. 2021;27(4):511–519. doi:10.1016/j.cmi.2021.01.011
   Web of Science ®Google Scholar
• Rada G, Corbalán J, Rojas P. Cell-based therapies for COVID-19: a living, systematic review. Medwave. 2020;20(11):e8079. doi:10.5867/medwave.2020.11.8078
   Web of Science ®Google Scholar
• Rocha APD, Atallah ÁN, Pinto A, et al. COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review. Sao Paulo Med J. 2020;138(6):515–520. doi:10.1590/1516-3180.2020.0421.R2.10092020
   Web of Science ®Google Scholar
• Salameh JP, Leeflang MM, Hooft L, et al. Thoracic imaging tests for the diagnosis of COVID-19. Cochrane Database Syst Rev. 2020;9:Cd013639. doi:10.1002/14651858.CD013639
   PubMedGoogle Scholar
• Schlesinger S, Neuenschwander M, Lang A, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 2021;64(7):1480–1491. doi:10.1007/s00125-021-05458-8
   PubMed Web of Science ®Google Scholar
• Schünemann HJ, Khabsa J, Solo K, et al. Ventilation techniques and risk for transmission of coronavirus disease, including COVID-19: a living systematic review of multiple streams of evidence. Ann Intern Med. 2020;173(3):204–216. doi:10.7326/m20-2306
   PubMed Web of Science ®Google Scholar
• Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, et al. Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis. BMJ. 2021;374:n2231. doi:10.1136/bmj.n2231
   PubMed Web of Science ®Google Scholar
• Siemieniuk RA, Bartoszko JJ, Ge L, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020;370:m2980.
   PubMed Web of Science ®Google Scholar
• Silveira FM, Mello ALR, da Silva Fonseca L, et al. Morphological and tissue-based molecular characterization of oral lesions in patients with COVID-19: a living systematic review. Arch Oral Biol. 2022;136:105374. doi:10.1016/j.archoralbio.2022.105374
   Web of Science ®Google Scholar
• Soto-Cámara R, García-Santa-Basilia N, Onrubia-Baticón H, et al. Psychological Impact of the COVID-19 pandemic on out-of-hospital health professionals: a living systematic review. J Clin Med. 2021;10(23). doi:10.3390/jcm10235578
   Web of Science ®Google Scholar
• Stroehlein JK, Wallqvist J, Iannizzi C, et al. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021;5(5):Cd015043. doi:10.1002/14651858.Cd015043
   PubMed Web of Science ®Google Scholar
• Tleyjeh IM, Kashour Z, Riaz M, et al. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update. Clin Microbiol Infect. 2021;27(8):1076–1082. doi:10.1016/j.cmi.2021.04.019
   PubMed Web of Science ®Google Scholar
• Valk SJ, Piechotta V, Chai KL, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;5(5):Cd013600. doi:10.1002/14651858.Cd013600
   PubMed Web of Science ®Google Scholar
• Verdejo C, Vergara-Merino L, Meza N, et al. Macrolides for the treatment of COVID-19: a living, systematic review. Medwave. 2020;20(11):e8074. doi:10.5867/medwave.2020.11.8073
   Web of Science ®Google Scholar
• Verdugo-Paiva F, Acuña MP, Solá I, et al. Remdesivir for the treatment of COVID-19: a living systematic review. Medwave. 2020;20(11):e8080. doi:10.5867/medwave.2020.11.8080
   Web of Science ®Google Scholar
• Verdugo-Paiva F, Izcovich A, Ragusa M, et al. Lopinavir-ritonavir for COVID-19: a living systematic review. Medwave. 2020;20(6):e7967. doi:10.5867/medwave.2020.06.7966
   Web of Science ®Google Scholar
• Wagner C, Griesel M, Mikolajewska A, et al. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2021;8(8):Cd014963. doi:10.1002/14651858.Cd014963
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Kaka AS, MacDonald R, et al. Remdesivir for adults with COVID-19: a living systematic review for American College of physicians practice points. Ann Intern Med. 2021;174(2):209–220. doi:10.7326/m20-5752
   PubMed Web of Science ®Google Scholar
• Webster KE, O'Byrne L, MacKeith S, et al. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2021;7(7):Cd013877. doi:10.1002/14651858.CD013877.pub2
   Web of Science ®Google Scholar
• Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi:10.1136/bmj.m1328
   PubMed Web of Science ®Google Scholar
• Xu W, Li X, Dong Y, et al. SARS-CoV-2 transmission in schools: an updated living systematic review. J Glob Health. 2021;11:10004. doi:10.7189/jogh.11.10004
   Web of Science ®Google Scholar
• Yang J, D’Souza R, Kharrat A, et al. Coronavirus disease 2019 pandemic and pregnancy and neonatal outcomes in general population: a living systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2022;101(1):7–24. doi:10.1111/aogs.14277
   Web of Science ®Google Scholar
• Zhang X, Shang L, Fan G, et al. The efficacy and safety of janus kinase inhibitors for patients with COVID-19: a living systematic review and meta-analysis. Front Med. 2021;8:800492. doi:10.3389/fmed.2021.800492
   Web of Science ®Google Scholar
• Dotto L, Kinalski MA, Machado PS, et al. The mass production of systematic reviews about COVID-19: an analysis of PROSPERO records. J Evid Based Med. 2021;14(1):56–64. doi:10.1111/jebm.12426
   Google Scholar
• Sideri S, Papageorgiou SN, Eliades T. Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. J Clin Epidemiol. 2018;100:103–110. doi:10.1016/j.jclinepi.2018.01.003
   PubMed Web of Science ®Google Scholar
• Chien PF, Khan KS, Siassakos D. Registration of systematic reviews: PROSPERO. BJOG. 2012;119(8):903–905. doi:10.1111/j.1471-0528.2011.03242.x
   PubMed Web of Science ®Google Scholar
• Ge L, Tian JH, Li YN, et al. Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study. J Clin Epidemiol. 2018;93:45–55. doi:10.1016/j.jclinepi.2017.10.012
   PubMed Web of Science ®Google Scholar
• Brierley L, Nanni F, Polka JK, et al. Tracking changes between preprint posting and journal publication during a pandemic. PLoS Biol. 2022;20(2):e3001285. doi:10.1371/journal.pbio.3001285
   Web of Science ®Google Scholar
• Rawlinson C, Bloom T. New preprint server for medical research. BMJ. 2019;365:l2301. doi:10.1136/bmj.l2301
   PubMed Web of Science ®Google Scholar
• Lansky A, Wethington HR. Living systematic reviews and other approaches for updating evidence. Am J Public Health. 2020;110(11):1687–1688. doi:10.2105/ajph.2020.305920
   Web of Science ®Google Scholar
• Thomas J, Noel-Storr A, Marshall I, et al. Living systematic reviews: 2. Combining human and machine effort. J Clin Epidemiol. 2017;91:31–37. doi:10.1016/j.jclinepi.2017.08.011
   PubMed Web of Science ®Google Scholar
• Chou R, Dana T, Shetty KD. Testing a machine learning tool for facilitating living systematic reviews of chronic pain treatments. In: AHRQ Methods for Effective Health Care. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020.
   Google Scholar
• Butcher R, Sampson M, Couban RJ, et al. The currency and completeness of specialized databases of COVID-19 publications. J Clin Epidemiol. 2022;147:52–59. doi:10.1016/j.jclinepi.2022.03.006
   PubMed Web of Science ®Google Scholar
• Rada G, Pérez D, Araya-Quintanilla F, et al. Epistemonikos: a comprehensive database of systematic reviews for health decision-making. BMC Med Res Methodol. 2020;20(1):286. doi:10.1186/s12874-020-01157-x
   PubMed Web of Science ®Google Scholar
• Pierre O, Riveros C, Charpy S, et al. Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19. J Clin Epidemiol. 2021;141:46–53. doi:10.1016/j.jclinepi.2021.09.022
   Web of Science ®Google Scholar
• Créquit P, Martin-Montoya T, Attiche N, et al. Living network meta-analysis was feasible when considering the pace of evidence generation. J Clin Epidemiol. 2019;108:10–16. doi:10.1016/j.jclinepi.2018.12.008
   Web of Science ®Google Scholar
• Tercero-Hidalgo JR, Khan KS, Bueno-Cavanillas A, et al. Artificial intelligence in COVID-19 evidence syntheses was underutilized, but impactful: a methodological study. J Clin Epidemiol. 2022;148:124–134. doi:10.1016/j.jclinepi.2022.04.027
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71–n71. doi:10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Whiting P, Savović J, Higgins JP, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–234. doi:10.1016/j.jclinepi.2015.06.005
   PubMed Web of Science ®Google Scholar
• Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. doi:10.1136/bmj.j4008
   PubMed Web of Science ®Google Scholar